Prof Jens Ricke talks to ecancer about the need to move away from pharmaceutically funded approaches to personalised medicine at the European Forum on Oncology in Berlin, May 2012.

Personalised medicine is an individual treatment for an individual patient’s unique disease. However, current clinical trials funded by pharmaceutical companies do not result in such treatments. Prof Ricke suggests selecting doctors from a large group of specialists to develop an individual plan for each patient.